All InsightsDownload This Document
With 9 in 10 M&A life sciences deals including an earnout, staying on top of deal terms and trends is vitally important to deal parties in the industry. Drawing on highlights from the 2023 SRS Acquiom Life Sciences M&A Study, plus new data for 2024, this info sheet explores:
- A due diligence spotlight
Defining diligence standards has never been more important in Bio/Pharma deals, especially in light of recent Delaware case law.1 Find out the latest on the Commercially Reasonable Efforts (CRE) standard and whether your deal is on trend. - The earnouts "sweet spot”
Only 7% of the earnout dollars for Bio/Pharma were paid out, according to the 2023 SRS Acquiom Life Sciences M&A Study. Learn more about early-stage vs. late-stage acquisitions and the difference that up-front payments can make in earnout achievement.
Download the Info Sheet now.
1: See SRS v. Alexion Pharmaceuticals (Del. Ch., September 2024) and Fortis v. Johnson & Johnson (Del. Ch., September 2024).
Kip Wallen
Senior Director, Thought Leadership tel:720-452-5364
Kip Wallen is a senior director leading the SRS Acquiom thought leadership practice. He leverages his extensive expertise and SRS Acquiom proprietary data to produce resourceful content regularly utilized by market practitioners. Kip has broad experience in M&A and provides guidance on market standards and trends.
Previously, Kip was a Director with the SRS Acquiom Transactional Group, where he collaborated with clients and counsel to negotiate M&A documents including purchase, escrow, payments, and other transactional agreements. Before joining SRS Acquiom, Kip was an attorney with a Denver-based boutique business law firm where he assisted clients with M&A transactions as well as general corporate governance and securities matters.
Kip is an avid supporter of the Colorado Symphony, serving as Treasurer and Trustee. He is an active participant on the American Bar Association’s M&A Committee. In 2016, Kip completed Leadership 20 with the Denver chapter of the Association for Corporate Growth.
Kip received his J.D. from the Sturm College of Law at the University of Denver and an M.S. in Economics, B.S. in Economics and B.A. in International Relations from Lehigh University. He is a member of the Colorado bar.